metoclopramide has been researched along with Tremor in 8 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tardive tremor is a 3-5 Hz bilateral resting and action tremor, associated with the use of dopamine receptor blocking drugs, accompanied by other tardive movement disorders and responsive to tetrabenazine or clozapine." | 7.78 | Sensory trick with metoclopramide-associated tardive tremor. ( Shprecher, D, 2012) |
| "Tardive tremor is a very uncommon neuroleptic-induced tardive syndrome which was initially described in five patients by Stacy and Jankovic (Stacy and Jankovic, Mov Disord 1992;7:53-57)." | 5.31 | Tardive tremor due to metoclopramide. ( Indorf, G; Tarsy, D, 2002) |
| "Tardive tremor is a 3-5 Hz bilateral resting and action tremor, associated with the use of dopamine receptor blocking drugs, accompanied by other tardive movement disorders and responsive to tetrabenazine or clozapine." | 3.78 | Sensory trick with metoclopramide-associated tardive tremor. ( Shprecher, D, 2012) |
| "Tardive tremor is a very uncommon neuroleptic-induced tardive syndrome which was initially described in five patients by Stacy and Jankovic (Stacy and Jankovic, Mov Disord 1992;7:53-57)." | 1.31 | Tardive tremor due to metoclopramide. ( Indorf, G; Tarsy, D, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shprecher, D | 1 |
| Tarsy, D | 1 |
| Indorf, G | 1 |
| Gorelik, AR | 1 |
| Williams, LS | 1 |
| Steward, JT | 1 |
| Indo, T | 1 |
| Ando, K | 1 |
| Ahronheim, JC | 1 |
| Acharya, SR | 1 |
| Kumar, TN | 1 |
| Vasshadhara, C | 1 |
| Bateman, DN | 1 |
| Kahn, C | 1 |
| Legg, NJ | 1 |
| Reid, JL | 1 |
| Gez, E | 1 |
| Catane, R | 1 |
| Pfau, L | 1 |
| Biran, S | 1 |
1 trial available for metoclopramide and Tremor
| Article | Year |
|---|---|
Metoclopramide in Parkinson's disease.
Topics: Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Humans; Metoclopramide; Middle | 1978 |
7 other studies available for metoclopramide and Tremor
| Article | Year |
|---|---|
Sensory trick with metoclopramide-associated tardive tremor.
Topics: Adrenergic Uptake Inhibitors; Aged; Blepharospasm; Cervical Vertebrae; Dopamine Antagonists; Humans; | 2012 |
Tardive tremor due to metoclopramide.
Topics: Aged; Dyskinesia, Drug-Induced; Female; Gastrointestinal Agents; Humans; Metoclopramide; Time Factor | 2002 |
Failure to thrive related to metoclopramide therapy.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antiemetics; Deglutition Disorders; Female; Hum | 2003 |
Metoclopramide-induced Parkinsonism. Clinical characteristics of ten cases.
Topics: Aged; Female; Gastrointestinal Diseases; Humans; Metoclopramide; Parkinson Disease, Secondary; Tremo | 1982 |
Metoclopramide and tremor.
Topics: Aged; Female; Humans; Metoclopramide; Tremor | 1982 |
Metoclopramide--a cholinomimetic tremorogen?
Topics: Animals; Basal Ganglia Diseases; Dogs; Guinea Pigs; Humans; Metoclopramide; Parasympathetic Nervous | 1982 |
High-dose metoclopramide as an antiemetic in patients receiving cis-platinum-based combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diarrhea; Female; Humans; Male; Metoclopr | 1985 |